© Pint of Science, 2024. All rights reserved.
Our Society focusses on 3 aspects of national and global health inequalities. We look at how acknowledging and overcoming racism may help create a better health policy nationally. There is also a focus on uptake of the Covid-19 vaccine in different ethnic groups. Finally, we address at a global level how more should be done to help protect those with Neglected Tropical Diseases.
Ethnic/race inequalities in health: moving beyond confusion to focus on fundamental causes
Professor James Nazroo
(Professor at the University of Manchester)
This discussion will focus on health inequalities in relation to race/ethnicity. The central argument is that to make sense of race/ethnic inequalities in health we must adopt a theoretically informed approach. This centres on fundamental causes of such inequalities that flow from structural, interpersonal and institutional racism. To understand the root causes requires examination of how racism operates to shape social and economic inequalities and thereby to shape health outcomes. Such an approach has direct, and helpful, implications for the development of policy.
Inequalities in the Covid-19 vaccine programme: evidence from Greater Manchester
Stephanie Gillibrand
(Research Associate, Applied Research Collaboration Greater Manchester, The University of Manchester)
The Covid-19 vaccination rollout presented new inequalities not previously seen in the seasonal flu vaccination programme. This presentation discusses the findings from a recent study done in Greater Manchester, which identifies inequities in the uptake of the Covid-19 vaccines, reflecting on the drivers of these inequalities and what we can learn from this moving forward.
Vaccine Development for Neglected Tropical Diseases
Dr Allison Bancroft
(Research Associate, The University of Manchester)
Long lived infection by parasitic worms affects up to 25% of the global population causing considerable morbidity and illness. Drug treatment results in rapid reinfection and with increasing cases of emerging drug resistance vaccines are urgently needed. 1 in 17 people are chronically infected with whipworm infection in areas of economic deprivation and poor sanitation. We use the very similar mouse whipworm to study vaccination in the laboratory. The most common secreted protein from mouse whipworm has unique features that we believe help the parasites survive and interestingly has also succe
Map data © OpenStreetMap contributors.